Related Experiment Video
Updated: Jun 12, 2026
08:28
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Asymptomatic congenital lead poisoning - case report
Nachammai R Chinnakaruppan1, Steven Matthew Marcus
1Neonatal Intensive Care Unit, Department of Pediatrics, Lehigh Valley Health Network, Allentown, PA 18105-1556, USA. abiarun53@gmail.com
Clinical Toxicology (Philadelphia, Pa.)
|June 11, 2010
Summary
Congenital lead poisoning in newborns is rare. Aggressive treatment, including exchange transfusion and chelation, can lead to favorable outcomes and normal development.
Area of Science:
- Pediatrics
- Toxicology
- Neonatal Care
Background:
- Congenital lead poisoning is an uncommon condition in newborns.
- There is a lack of established guidelines for managing neonatal lead exposure.
- Maternal lead burden poses a significant risk to the developing fetus.
Observation:
- A neonate presented with a high blood lead level (BLL) of 72 μg/dL shortly after birth.
- The infant's mother had a pre-delivery BLL of 58 μg/dL, indicating significant maternal lead exposure.
- Elevated free erythrocyte protoporphyrin (FEP) levels were also noted in the infant (175 μg/dL).
Findings:
- The infant underwent immediate exchange transfusion, rapidly reducing the BLL to 11.4 μg/dL within 6 hours.
- Subsequent chelation therapy was administered as part of the treatment protocol.
- Two-year follow-up revealed a normalized BLL of 9 μg/dL and normal neurodevelopmental outcomes.
Implications:
- Aggressive management strategies, including transfusion and chelation, are effective for severe congenital lead poisoning.
- Early intervention can prevent long-term neurodevelopmental deficits associated with lead exposure.
- This case highlights the importance of maternal lead screening and prompt neonatal intervention.
Related Concept Videos
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...